John Curnutte

John T.
Curnutte was the founder of Sagimet Biosciences, Inc., founded in 2007, where he served as Chief Executive Officer from 2007 to 2010.
Dr. Curnutte currently serves as Independent Director at Pliant Therapeutics, Inc. since 2017 and as Director at Autobahn Labs, Inc. Former jobs included Chief Executive Officer at Sagimet Biosciences, Inc. from 2008 to 2010; Senior Director at Genentech, Inc. in 2000; Independent Director at Diadexus, Inc. from 2015 to 2016; Independent Non-Executive Director at Orchard Therapeutics Plc from 2019 to 2024; Co-President and EVP-Research & Development at Portola Pharmaceuticals LLC in 2018; President at Schering-Plough Biopharma in 2008; Member-Medical Staff at Stanford University School of Medicine from 1993 to 2013; Senior Advisor at Samsara BioCapital LLC; and Senior Vice President-Discovery Research at Schering-Plough Research Institute.
Education includes a doctorate from Harvard Medical School conferred in 1973 and an undergraduate degree from Harvard University conferred in 1980.